Clinical Trials on Pelvis in Hong Kong
Total 15 results
-
Hong Kong Baptist UniversityInnovation and Technology Commission, Hong KongRecruiting
-
Chinese University of Hong KongKwong Wah HospitalRecruitingPelvic Organ ProlapseHong Kong
-
The University of Hong KongCompletedSexually Transmitted Infections | Induced Abortion | Postaboral Pelvic Inflammatory DiseaseChina
-
The University of Hong KongPamela Youde Nethersole Eastern Hospital, Hong Kong; United Christian HospitalActive, not recruitingPelvic MassHong Kong
-
Chinese University of Hong KongRecruiting
-
Chinese University of Hong KongNot yet recruitingRecurrent MiscarriageHong Kong
-
Prof. Yuen Chun-WahDr. Cheung Hing Cheong Private Dermatology ClinicCompletedTinea PedisHong Kong
-
AO Innovation Translation CenterRecruitingPelvic FractureNetherlands, Germany, Hong Kong, United States, Canada, Japan, Switzerland
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
CHA MEDITECH Co., Ltd.CompletedPenile Enhancement | Small PenisKorea, Republic of
-
PfizerCompletedChronic Prostatitis With Chronic Pelvic Pain SyndromeUnited States, Canada, France, Sweden, Switzerland
-
Encube Ethicals Pvt. Ltd.Novum Pharmaceutical Research Services; ACM Global LaboratoriesCompletedTinea PedisUnited States, Belize, Saint Lucia
-
PfizerCompletedPelvic Inflammatory DiseaseJapan
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedEndometriosis | Dysmenorrhea | Pelvic Pain | DyspareuniaHong Kong, United States, Canada, Australia, United Kingdom, South Africa, Belgium
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States